Misonix announces results of new large real-world studies that further prove efficacy of TheraSkin
Diabetic ulcers were 59% more likely to close in the treatment cohort, compared to the control cohort
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Dec 19
Diabetic ulcers were 59% more likely to close in the treatment cohort, compared to the control cohort
05 Dec 19
The Prototype Lab is an innovative space for physicians, researchers, engineers and other healthcare professionals to develop their…
04 Dec 19
The study enrolled approximately 150 patients who were 50-80 years of age from 19 sites across the United…
04 Dec 19
The clinical trial will demonstrate the safety and effectiveness of Renuvion technology for use in dermal resurfacing procedures
03 Dec 19
GE Healthcare’s investment in CMR Surgical, further demonstrates its commitment to improve outcomes for healthcare providers and therapy…
02 Dec 19
Flexible bioactive glass can be 3D-printed into scaffolds, which stimulate cells to produce a cartilage matrix unlike any…
28 Nov 19
Venus Epileve represents a new product introduction that expands the Company’s diode laser hair removal offering beyond the…
20 Nov 19
Concord invested to accelerate CI Security’s already impressive growth in the healthcare sector
20 Nov 19
The facility currently features 15,000 square feet of new Class 7 clean room space for production of complex…
19 Nov 19
Freudenberg Medical is a global partner for the design, development and manufacture of innovative medical devices, components, and…